Latest articles about Japanese Encephalitis Routine vaccines: Japanese Encephalitis
Lao PDR became the first country to conduct a JE campaign with Gavi support in 2015
More than 18 million children immunised by the end of 2018
In April 2015, the Lao People’s Democratic Republic (Lao PDR) became the first country to run a Gavi-supported Japanese encephalitis (JE) campaign. This was just 18 months after WHO added a JE vaccine developed by Chengdu Institute of Biological Products to the list of prequalified vaccines that United Nations agencies can procure.
Following the success of the catch-up campaign, Lao PDR added JE vaccine to its routine immunisation schedule.
In June 2016, the Gavi Board agreed to co-finance countries’ routine Japanese encephalitis vaccine programmes in addition to funding catch-up campaigns. As a result, Gavi is increasing its support for this life-saving vaccine and helping the region take the necessary steps to reduce the JE disease burden in the long term.
OVER 18 MILLION CHILDREN REACHED
By the end of 2018, more than 1.6 million children had been immunised through Gavi-supported routine immunisation programmes and more than 16 million children through catch-up campaigns, totalling over 18 million children reached.
In 2018, Indonesia introduced the JE vaccine on the island of Bali through a campaign and into the routine immunisation system. Since support for the vaccine began, five Gavi-supported countries (Lao PDR, Nepal, Myanmar, Cambodia, and Indonesia) affected by JE have introduced the vaccine to prevent the effects of this potentially deadly disease.
The Alliance has drawn on the strengths of its individual partners to accelerate access to JE vaccine, which has a long manufacturing lead-time. WHO, UNICEF’s Supply Division, PATH and the Bill & Melinda Gates Foundation all play a critical role in ensuring sufficient supply of the vaccine to countries in need as well as the technical assistance needed to make decisions for introduction and implementation.